Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
Clinical trial NCT01452815 · COMPLETED
Trial details
- NCT number
- NCT01452815
- Sponsor
- Tranzyme, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-11-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.